4 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE (TRANSEURO)
Date du début: 1 janv. 2010, Date de fin: 30 juin 2016,
There are currently no cures for Parkinson's disease (PD) but one of the most effective reparative therapies in patients to date has been with allotransplants of dopamine (DA) neuroblasts obtained from fetal ventral mesencephalic (VM) tissue. However, this cell transplantation approach has given inconsistent results, with some patients doing extremely well and coming off anti-PD medication for yea ...
Voir le projet
15
Participants partenaires
TERMINÉ
Phase II clinical trial of PDGF-BB for the neurological regeneration and recovery in Parkinson´s disease (NRT)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2015,
"The goal of this project is to perform a European phase II clinical trial to demonstrate that PDGF-BB acts as a unique regenerative therapy for Parkinson’s Disease (PD), aimed at reversing the course of the disease, by promotion of endogenous brain repair mechanisms. Current pharmacological therapies for PD carry side-effects and become less effective as the disease progresses. This causes immen ...
Voir le projet
10
Participants partenaires
TERMINÉ
Regenerative medicine in Europe: emerging needs and challenges in a global context (REMEDiE)
Date du début: 1 mai 2008, Date de fin: 30 avr. 2011,
The globalization of regenerative medicine is gathering pace yet has not been examined with respect to its medium and long term implications for European regulators, the corporate sector or patients located within different member states. Over the coming years it is hypothesised that the global pace of change in this field will be extensive and this needs to be both tracked and assessed for health ...
Voir le projet
7
Participants partenaires
TERMINÉ
Biobanking and Biomolecular Resources Research Infrastructure (BBMRI)
Date du début: 1 févr. 2008, Date de fin: 31 janv. 2011,
...ses sustainability due to the lack of long-term funding. BBMRI will comprise: • biobanks of different formats (collections of blood, DNA, tissue, etc., together with medical, environmental, life-style and follow-up data), • biomolecular resources (antibody and affinity binder collections, ORF clone collections, siRNA libraries, proteins, cellular resources etc.), • enabling technologies and high-t ...
Voir le projet